Zefway 100 Oral Suspension contains Cefixime 100 mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of Gram-positive and Gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections such as bronchitis, pneumonia, and pharyngitis; urinary tract infections; otitis media; and uncomplicated gonorrhea. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The oral suspension formulation allows for ease of administration, particularly in pediatric patients or those with difficulty swallowing tablets. Zefway 100 should be used in accordance with susceptibility testing and clinical judgment to reduce the development of bacterial resistance. The usual dosage varies depending on the severity and type of infection, with adjustments recommended for patients with renal impairment. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain, as well as hypersensitivity reactions in susceptible individuals. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Zefway 100 Oral Suspension should be stored at controlled room temperature and shaken well before use to ensure uniform distribution of the active ingredient. Complete the full course of therapy to achieve optimal clinical outcomes and prevent resistance.